Bicara Therapeutics Inc. ... (BCAX)
Bicara Therapeutics Common Stock Max Pain By Strike
BCAX trades at $11.43, 14.3% above the near-term max pain of $10 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2.5-$10), reflecting growing call interest at higher strikes. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Bicara Therapeutics Common Stock Max Pain By Expiry
Max pain for BCAX shows an upward trend from 2.5 to 10, suggesting bullish positioning in longer-dated options. The 125% spread signals divergent expectations across timeframes. Most levels below 11.43 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 10 | -1.43 (-12.51%) |
| Sep 19, 2025 | 2.5 | -8.93 (-78.13%) |
| Oct 17, 2025 | 7.5 | -3.93 (-34.38%) |
| Jan 16, 2026 | 7.5 | -3.93 (-34.38%) |
| Apr 17, 2026 | 2.5 | -8.93 (-78.13%) |